Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) 用于 Age-Related Cognitive Decline

A

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

结论

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

Key Study Findings

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None vs: None Outcome: Neurological health outcomes 效果: None None

研究人群: None

Review
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.
Dose: None vs: None Outcome: None 效果: None None

研究人群: None

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD 效果: None None

研究人群: Alzheimer's disease patients

Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None vs: None Outcome: None 效果: None None

研究人群: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None vs: None Outcome: None 效果: None None

研究人群: None

In Vitro
Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry.
Dose: None vs: None Outcome: Age-dependent brain lipid changes 效果: None None

研究人群: Mice: adult (3-4mo), middle-aged (10mo), old (19-21mo)

Key Statistics

58

研究数量

12000

受试者

Positive

A

等级

Referenced Papers

Molecules (Basel, Switzerland) 2025 10 次引用
Journal of Alzheimer's … 2025 3 次引用
Nutrients 2025 2 次引用
Current opinion in … 2023 58 次引用
Nutrients 2022 76 次引用
International journal of … 2022 23 次引用
Current nutrition reports 2019 310 次引用
Nutricion hospitalaria 2019 40 次引用
American family physician 2018 101 次引用
Nutricion hospitalaria 2018 32 次引用
Advances in nutrition … 2017 215 次引用
Advances in nutrition … 2013 155 次引用
Current treatment options … 2011 6 次引用
Molecular neurobiology 2010 145 次引用
Women's health (London, … 2010 48 次引用
JAMA 2010 3 次引用
The Practitioner 2010
The Cochrane database … 2009 299 次引用
Prostaglandins, leukotrienes, and … 2009 258 次引用
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 次引用
Prostaglandins, leukotrienes, and … 2006 176 次引用
Medecine sciences : … 2005 19 次引用
The Cochrane database … 2003 263 次引用
Journal of Alzheimer's … 2003 161 次引用
Pharmacological research 1999 1060 次引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

常用剂量

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

上限: 3,000 mg/day combined DHA/EPA (FDA GRAS)

研究中使用的剂量

剂量 持续时间 效果 N
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA 4 weeks Positive 50
None -- Mixed --

最佳服用时间: With meals containing fat for better absorption

Safety & Side Effects

已报告的副作用

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

已知相互作用

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

可耐受最高摄入量: 3,000 mg/day combined DHA/EPA (FDA GRAS)

在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Age-Related Cognitive Decline?
Based on 58 studies with 12,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (DHA/EPA) may support Age-Related Cognitive Decline management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Age-Related Cognitive Decline?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 58 peer-reviewed studies with 12,000 total participants. The overall direction of effect is positive.

Related Evidence

FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。